AIMS: Metaplastic breast carcinoma (MBC) is a rare type of triple-negative breast cancer that shows vast histological and genetic heterogeneity. Osseous differentiation can be found in different subtypes of MBC. Whether MBCs with osseous differentiation are underpinned by specific genetic alterations has yet to be defined. The aim of this study was to investigate the repertoire of somatic mutations and copy number alterations (CNAs) in three MBCs with extensive osseous differentiation. METHODS AND RESULTS: Tumour and normal DNA samples from three MBCs with extensive osseous differentiation were subjected to whole-exome sequencing. Somatic mutations, CNAs and mutational signatures were determined by use of a validated bioinformatics pipeline. Our analyses revealed clonal TP53 hotspot mutations associated with loss of heterozygosity of the wild-type allele coupled with mutations affecting genes related to the Wnt and/or the phosphoinositide 3-kinase-AKT-mammalian target of rapamycin pathways in all cases analysed. All cases showed a dominant mutational signature 1, with two cases showing a secondary signature 3 in addition to other features of homologous recombination DNA repair defects. The oncostatin M receptor gene, which plays a role in mesenchymal differentiation and bone formation, was found to be mutated in two MBCs with extensive osseous differentiation and in none of 35 previously published 35 MBCs. CONCLUSION: Our findings suggest that MBCs with osseous differentiation have somatic mutations similar to those of other forms of MBC.
AIMS: Metaplastic breast carcinoma (MBC) is a rare type of triple-negative breast cancer that shows vast histological and genetic heterogeneity. Osseous differentiation can be found in different subtypes of MBC. Whether MBCs with osseous differentiation are underpinned by specific genetic alterations has yet to be defined. The aim of this study was to investigate the repertoire of somatic mutations and copy number alterations (CNAs) in three MBCs with extensive osseous differentiation. METHODS AND RESULTS: Tumour and normal DNA samples from three MBCs with extensive osseous differentiation were subjected to whole-exome sequencing. Somatic mutations, CNAs and mutational signatures were determined by use of a validated bioinformatics pipeline. Our analyses revealed clonal TP53 hotspot mutations associated with loss of heterozygosity of the wild-type allele coupled with mutations affecting genes related to the Wnt and/or the phosphoinositide 3-kinase-AKT-mammalian target of rapamycin pathways in all cases analysed. All cases showed a dominant mutational signature 1, with two cases showing a secondary signature 3 in addition to other features of homologous recombination DNA repair defects. The oncostatin M receptor gene, which plays a role in mesenchymal differentiation and bone formation, was found to be mutated in two MBCs with extensive osseous differentiation and in none of 35 previously published 35 MBCs. CONCLUSION: Our findings suggest that MBCs with osseous differentiation have somatic mutations similar to those of other forms of MBC.
Authors: Charlotte K Y Ng; Salvatore Piscuoglio; Felipe C Geyer; Kathleen A Burke; Fresia Pareja; Carey A Eberle; Raymond S Lim; Rachael Natrajan; Nadeem Riaz; Odette Mariani; Larry Norton; Anne Vincent-Salomon; Y Hannah Wen; Britta Weigelt; Jorge S Reis-Filho Journal: Clin Cancer Res Date: 2017-02-02 Impact factor: 12.531
Authors: Britta Weigelt; Charlotte K Y Ng; Ronglai Shen; Tatiana Popova; Michail Schizas; Rachael Natrajan; Odette Mariani; Marc-Henri Stern; Larry Norton; Anne Vincent-Salomon; Jorge S Reis-Filho Journal: Mod Pathol Date: 2014-11-21 Impact factor: 7.842
Authors: Emma C Walker; Narelle E McGregor; Ingrid J Poulton; Melissa Solano; Sueli Pompolo; Tania J Fernandes; Matthew J Constable; Geoff C Nicholson; Jian-Guo Zhang; Nicos A Nicola; Matthew T Gillespie; T John Martin; Natalie A Sims Journal: J Clin Invest Date: 2010-01-04 Impact factor: 14.808
Authors: Debyani Chakravarty; Jianjiong Gao; Sarah M Phillips; Ritika Kundra; Hongxin Zhang; Jiaojiao Wang; Julia E Rudolph; Rona Yaeger; Tara Soumerai; Moriah H Nissan; Matthew T Chang; Sarat Chandarlapaty; Tiffany A Traina; Paul K Paik; Alan L Ho; Feras M Hantash; Andrew Grupe; Shrujal S Baxi; Margaret K Callahan; Alexandra Snyder; Ping Chi; Daniel Danila; Mrinal Gounder; James J Harding; Matthew D Hellmann; Gopa Iyer; Yelena Janjigian; Thomas Kaley; Douglas A Levine; Maeve Lowery; Antonio Omuro; Michael A Postow; Dana Rathkopf; Alexander N Shoushtari; Neerav Shukla; Martin Voss; Ederlinda Paraiso; Ahmet Zehir; Michael F Berger; Barry S Taylor; Leonard B Saltz; Gregory J Riely; Marc Ladanyi; David M Hyman; José Baselga; Paul Sabbatini; David B Solit; Nikolaus Schultz Journal: JCO Precis Oncol Date: 2017-05-16
Authors: Nicolai J Birkbak; Zhigang C Wang; Daniel P Silver; Zoltan Szallasi; Andrea L Richardson; Ji-Young Kim; Aron C Eklund; Qiyuan Li; Ruiyang Tian; Christian Bowman-Colin; Yang Li; April Greene-Colozzi; J Dirk Iglehart; Nadine Tung; Paula D Ryan; Judy E Garber Journal: Cancer Discov Date: 2012-03-22 Impact factor: 39.397
Authors: Felipe C Geyer; Britta Weigelt; Rachael Natrajan; Maryou B K Lambros; Dario de Biase; Radost Vatcheva; Kay Savage; Alan Mackay; Alan Ashworth; Jorge S Reis-Filho Journal: J Pathol Date: 2010-04 Impact factor: 7.996
Authors: Nadeem Riaz; Pedro Blecua; Raymond S Lim; Ronglai Shen; Daniel S Higginson; Nils Weinhold; Larry Norton; Britta Weigelt; Simon N Powell; Jorge S Reis-Filho Journal: Nat Commun Date: 2017-10-11 Impact factor: 14.919
Authors: Xue Chao; Wanlin Tan; Julia Y Tsang; Gary M Tse; Jintao Hu; Ping Li; Jinghui Hou; Mei Li; Jiehua He; Peng Sun Journal: Breast Cancer Date: 2021-05-03 Impact factor: 4.239
Authors: Edaise M da Silva; Pier Selenica; Mahsa Vahdatinia; Fresia Pareja; Arnaud Da Cruz Paula; Lorenzo Ferrando; Andrea M Gazzo; Higinio Dopeso; Dara S Ross; Ariya Bakhteri; Nadeem Riaz; Sarat Chandarlapaty; Pedram Razavi; Larry Norton; Hannah Y Wen; Edi Brogi; Britta Weigelt; Hong Zhang; Jorge S Reis-Filho Journal: NPJ Breast Cancer Date: 2021-04-16